Trial
NCT03563040
Study of Photopheresis in the Treatment of Erythrodermic MF and SS
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Mallinckrodt
Condition
Lymphoma, T-Cell, Cutaneous
Intervention
Methoxsalen
Why stopped
Lack of feasibility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-08